With regard to the p-tau relative abundance as evaluated by Western blot, after the Kruskal–Wallis rank test (χ2(2) = 2.712, p = 0.257), no differences among the three groups (AD, MCI, and control group) were highlighted. This evidence concerns the gene MAPT and Alzheimer disease.